Abraxane and haematocrit decreased Patient Reports February 11, 2012

Abraxane Side Effects Report #6045072-6
Abraxane side effect was reported by a Health Professional from UNITED STATES on Jan 16, 2009. Male patient, weighting 154.3 lb, was diagnosed with pancreatic carcinoma and was treated with Abraxane. After drug was administered, patient experienced the following side effects: back disorder, gastrointestinal ulcer haemorrhage, haematocrit decreased, syncope. Abraxane dosage: 389 MG D1/CYCLE 042. During the same period patient was treated with VANDETANIB, CREON, LOTENSIN, PROTONIX, INSULIN PUMP, AMLODIPINE. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5920899-7
Abraxane side effect was reported by a Health Professional from UNITED STATES on Oct 15, 2008. Female patient, weighting 141.0 lb, was diagnosed with ovarian cancer recurrent and was treated with Abraxane. After drug was administered, patient experienced the following side effects: condition aggravated, haematocrit decreased, haemoglobin decreased, vaginal haemorrhage, white blood cell count decreased. Abraxane dosage: 260 MG/ M2 ONCE EVERY 21 DAYS IV. During the same period patient was treated with VANDETANIB. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5084304-8
Abraxane side effect was reported by a Health Professional from UNITED STATES on Aug 01, 2006. Male patient, 68 years of age, weighting 198.0 lb, was diagnosed with non-small cell lung cancer and was treated with Abraxane. After drug was administered, patient experienced the following side effects: aptyalism, constipation , decreased appetite, febrile neutropenia, haematocrit decreased, haemoglobin decreased, hypokalaemia, hypomagnesaemia, platelet count decreased. Abraxane dosage: 2 DOSES (600 MG) INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, AVASTIN. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #6002600-4
Abraxane side effect was reported by a Physician from UNITED STATES on Dec 01, 2008. Male patient, 69 years of age, weighting 179.9 lb, was diagnosed with metastatic malignant melanoma and was treated with Abraxane. After drug was administered, patient experienced the following side effects: asthenia, atrial fibrillation , blood pressure systolic decreased, calculus ureteric, chest pain , dehydration, dyspnoea, haematocrit decreased, haemoglobin decreased. Abraxane dosage: LAST DOSE PRIOR TO SAE 15SEP08 307.5MG (307.5 MG), INTRAVENOUS. During the same period patient was treated with BEVACIZUMAB, TOPAMAX, ELAVIL, LIPITOR, CELEBREX, PROZAC, PROTONIX, VICODIN. Patient was hospitalized. Patient recovered.


Abraxane Side Effects Report #6026083-3
Abraxane side effect was reported by a Physician from UNITED STATES on Dec 18, 2008. Male patient, 60 years of age, weighting 178.8 lb, was diagnosed with head and neck cancer  and was treated with Abraxane. After drug was administered, patient experienced the following side effects: aspiration, choking , dyspnoea, haematocrit decreased, haemoglobin decreased, tachycardia, vomiting. Abraxane dosage: (42 MG), INTRANEOUS. During the same period patient was treated with ERBITUX, CARBOPLATIN, ATIVAN, DECADRON, DIFLUCAN, FENTANYL, FLONASE, KBL SOLUTION. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #4777270-3
Abraxane side effect was reported by a Physician from UNITED STATES on Aug 30, 2005. Female patient, 68 years of age, weighting 123.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: aphasia , arthralgia, blood culture positive, escherichia infection, haematocrit decreased, haemoglobin decreased, lethargy, listeriosis, neutropenia. Abraxane dosage: (400 MG, EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with ACIPHEX, CELEBREX, HYDROCHLOROTHIAZIDE. Patient died on 08/23/2005.

Abraxane Side Effects Report #5227176-0
Abraxane side effect was reported by a Health Professional from UNITED STATES on Jan 17, 2007. Female patient, 61 years of age, weighting 175.2 lb, was diagnosed with breast cancer  and was treated with Abraxane. After drug was administered, patient experienced the following side effects: anorexia, dehydration, fatigue, haematocrit decreased, haemoglobin decreased, hypokalaemia, international normalised ratio increased, prothrombin time prolonged, white blood cell count decreased. Abraxane dosage: 338 MG/ CYCLE 5, DAY 20/ DATE OF LAST DOSE GIVEN 27NOV06 (175 MG/M2), INTRAVENOUS. During the same period patient was treated with EPIRUBICIN, GEMCITABINE, COUMADIN, DIOVAN, TOPROL. Patient was hospitalized. Patient recovered.